148 related articles for article (PubMed ID: 12790512)
1. Hepatitis C virus therapies: current treatments, targets and future perspectives.
Walker MP; Appleby TC; Zhong W; Lau JY; Hong Z
Antivir Chem Chemother; 2003 Jan; 14(1):1-21. PubMed ID: 12790512
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis C: therapeutic perspectives.
Cornberg M; Wedemeyer H; Manns MP
Forum (Genova); 2001; 11(2):154-62. PubMed ID: 11948360
[TBL] [Abstract][Full Text] [Related]
3. Dynamic evolution of therapy for chronic hepatitis C: how will novel agents be incorporated into the standard of care?
Zeuzem S; Nelson DR; Marcellin P
Antivir Ther; 2008; 13(6):747-60. PubMed ID: 18839776
[TBL] [Abstract][Full Text] [Related]
4. Future therapy of hepatitis C.
McHutchison JG; Patel K
Hepatology; 2002 Nov; 36(5 Suppl 1):S245-52. PubMed ID: 12407600
[TBL] [Abstract][Full Text] [Related]
5. [Treatment of chronic hepatitis C].
Rókusz L
Orv Hetil; 2004 Aug; 145(32):1649-53. PubMed ID: 15384863
[TBL] [Abstract][Full Text] [Related]
6. Therapy of hepatitis C: from empiricism to eradication.
Pawlotsky JM
Hepatology; 2006 Feb; 43(2 Suppl 1):S207-20. PubMed ID: 16447262
[TBL] [Abstract][Full Text] [Related]
7. Promising candidates for the treatment of chronic hepatitis C.
Walker MP; Yao N; Hong Z
Expert Opin Investig Drugs; 2003 Aug; 12(8):1269-80. PubMed ID: 12882616
[TBL] [Abstract][Full Text] [Related]
8. Impact of ribavirin on HCV replicon RNA decline during treatment with interferon-α and the protease inhibitors boceprevir or telaprevir.
Hofmann WP; Chung TL; Osbahr C; Susser S; Karey U; Mihm U; Welsch C; Lötsch J; Sarrazin C; Zeuzem S; Herrmann E
Antivir Ther; 2011; 16(5):695-704. PubMed ID: 21817191
[TBL] [Abstract][Full Text] [Related]
9. New treatments for chronic hepatitis C virus infection.
Corouge M; Pol S
Med Mal Infect; 2011 Nov; 41(11):579-87. PubMed ID: 21764234
[TBL] [Abstract][Full Text] [Related]
10. New HCV therapies on the horizon.
Vermehren J; Sarrazin C
Clin Microbiol Infect; 2011 Feb; 17(2):122-34. PubMed ID: 21087349
[TBL] [Abstract][Full Text] [Related]
11. [Hepatitis C virus infection--after 12 years. Advances in the management of chronic hepatitis C].
Pár A
Orv Hetil; 2002 Dec; 143(48):2667-74. PubMed ID: 12501575
[TBL] [Abstract][Full Text] [Related]
12. The hepatitis C revolution part 1: antiviral treatment options.
Thiagarajan P; Ryder SD
Curr Opin Infect Dis; 2015 Dec; 28(6):563-71. PubMed ID: 26524328
[TBL] [Abstract][Full Text] [Related]
13. [Inhibitors of hepatitis C virus--current standards and status of investigations].
Godzik P; Komorowski M; Cielecka-Kuszyk J; Madaliński K
Przegl Epidemiol; 2010; 64(4):473-8. PubMed ID: 21473060
[TBL] [Abstract][Full Text] [Related]
14. Does antiviral therapy reduce the risk of hepatocellular carcinoma in patients with chronic hepatitis C?
Michielsen P; Ho E; Francque S
Minerva Gastroenterol Dietol; 2012 Mar; 58(1):65-79. PubMed ID: 22419005
[TBL] [Abstract][Full Text] [Related]
15. Occult HBV infection and suppression of HCV replication in the early phase of combination therapy for chronic hepatitis C.
Ferraro D; Bonura C; Giglio M; Di Stefano R; Almasio PL; Di Marco V; Craxì A; Cacciola I; Squadrito G; Raimondo G
J Biol Regul Homeost Agents; 2003; 17(2):172-5. PubMed ID: 14518718
[TBL] [Abstract][Full Text] [Related]
16. Vitamin D in addition to peg-interferon-alpha/ribavirin in chronic hepatitis C virus infection: ANRS-HC25-VITAVIC study.
Terrier B; Lapidus N; Pol S; Serfaty L; Ratziu V; Asselah T; Thibault V; Souberbielle JC; Carrat F; Cacoub P
World J Gastroenterol; 2015 May; 21(18):5647-53. PubMed ID: 25987791
[TBL] [Abstract][Full Text] [Related]
17. [Therapy of hepatitis C].
Moradpour D; Blum HE
Praxis (Bern 1994); 2002 May; 91(22):977-82. PubMed ID: 12094432
[TBL] [Abstract][Full Text] [Related]
18. Current and evolving therapies for hepatitis C.
Moradpour D; Blum HE
Eur J Gastroenterol Hepatol; 1999 Nov; 11(11):1199-202. PubMed ID: 10563526
[TBL] [Abstract][Full Text] [Related]
19. A European single centre experience of management of hepatitis C virus genotype 4 infection with pegylated-interferon and ribavirin.
Selvapatt N; Habibi MS; Brown A
J Med Virol; 2015 Oct; 87(10):1716-21. PubMed ID: 25914248
[TBL] [Abstract][Full Text] [Related]
20. [Treatment of hepatitis C virus infection].
Zeuzem S
Praxis (Bern 1994); 2005 May; 94(18):721-6. PubMed ID: 15938383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]